Drug Discovery

A novel small molecule aims to tackle both Alzheimer’s disease and Dravet syndrome.

Dale Thomas, Co-founder of Mytide, explains how AI can be used for the discovery and development of peptide therapeutics.

As the new virus spreads, more information is needed to mount an appropriate response.

Bacteria shredding liquid metals to fight drug-resistant superbugs.

Keeping the patient in mind is crucial for clinical research.

Can open source by applied to pharma R&D? This is the aim of Molecule.

A new computational tool could help improve the stability and predictability of ADCs.

With many cell and gene therapies skipping phase III trials entirely, academics must get to grips with GMP early.

Miguel Forte argues it’s time to fine tune the way we target solid tumors...

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."